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Abstract
Background: The WHO recommends that individuals exposed to persons with multidrug resistant tuberculosis
(MDRTB) should be screened for active TB and followed up for 2 years to detect and treat secondary cases early.
Resource prioritisation means this is rarely undertaken and where it is performed it’s usually using a paper-based
record, without collation of data. Electronic data collection into a web-based registry offers the opportunity for
simplified and systematic TB contact surveillance with automatic synthesis of data at local, regional and national
level. This pilot study was designed to explore the feasibility of usage of a novel e-registry tool and explore
obstacles and facilitating factors to implementation.
Methods: In parallel with their paper records, seven dispensaries in Ulaanbaatar, Mongolia collected standardized
data electronically using Open Data Kit (ODK). Patients with MDRTB and their contacts were recruited during a single
clinic visit. Staff and patients were interviewed to gain insights into acceptability and to identify areas for improvement.
Results: Seventy household contacts of 32 MDR-TB index patients were recruited. 7/70 contacts (10%) traced had
active TB at the time they were recruited to the e-registry.
Paper registry satisfaction was low; 88% of staff preferred the e-registry as it was perceived as faster and more secure.
Patients and their contacts were generally supportive of the e-registry; however, a significant minority 10/42 (24%) of
index cases who were invited, declined to participate in the e-registry, with data security cited as their top concern.
Conclusion: E-registries are a promising tool for MDRTB contact tracing, but their acceptability amongst patients
should not be taken for granted.
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Background
Despite having been recommended by the World Health
Organization (WHO) since 2006, and repeatedly there-
after [1–6], contact tracing for multidrug resistant tuber-
culosis (MDRTB), remains a low priority within national
TB programs in many low and middle-income countries
where TB burden is high. In 2017, only a quarter of the
estimated 558,000 rifampicin resistant and multidrug
resistant tuberculosis (RR/MDRTB) cases worldwide
were enrolled on effective treatment, with many dying
even before a diagnosis could be made [7]. Significant
improvement in MDRTB case ascertainment is essential
to meet the END-TB strategy targets on reducing TB
incidence and mortality [6, 7]. Observational data in
support of the need to provide treatment for latent TB
infection (LTBI) presumed to be MDR is gradually
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accumulating [8, 9] and three randomised controlled tri-
als of preventive therapy for MDR exposed contacts are
now underway [10–12].
Meta analyses of MDRTB contact tracing studies have
shown that 41.3–61.3% of household contacts have la-
tent TB infection, and that 3.4–6.5% develop active dis-
ease [13–15]. Despite significant heterogeneity in the
studies included in these systematic reviews they have
consistently identified a substantial yield of secondary
tuberculosis cases among household and close contacts.
Most secondary cases tested also had MDR and were
diagnosed shortly after the index case [14].
The WHO has developed a set of global recommenda-
tions for TB contact investigation and these encourage the
use of a set of standardised approaches to programme
monitoring and evaluation. Heterogeneity of data collec-
tion between centres and of clinical definitions in datasets
collected by various agencies remain a barrier to effective
global monitoring. Whilst the WHO guidelines include
precise definitions of index cases, close contacts and
household contacts [5, 16, 17], a minimum dataset for an
MDRTB contact registry has yet to be internationally
agreed [9, 18] and no agency currently provides support in
the form of data collection tools through which such a
dataset could be uniformly collected, aggregated, analysed
and disseminated.
A variety of electronic TB registries and surveillance sys-
tems have been reported in recent years, including ETR.
net (www.etrnet.info), ENRS (ccs.gov.eg/ntp/M_E_ENRS.
htm), and e-TB manager (etbmanager.org/) [19, 20].
Open Data Kit (ODK, https://opendatakit.org) is a free
open source data collection toolkit allowing developers
to design forms for an android application (app) ODK
collect. Working in Botswana, Ha and colleagues developed
an electronic data collection (EDC) solution based on ODK
and used this to facilitate screening of TB contacts during
household visits [21]. They concluded that using ODK re-
duced the time taken to complete tracing for each contact
and scored favourably for user satisfaction among the
health workers who conducted the tracing [21].
Paper based methods remain the standard approach in
those few countries which currently undertake any
MDRTB contact tracing with or without subsequent sur-
veillance. Very few studies have evaluated the feasibility
and acceptability of EDC tools in these countries [22].
Where these have been addressed, data accuracy and
completeness remain an issue and none of this work has
been completed in MDRTB contact tracing [23, 24]. In
this study we aimed to evaluate the feasibility of a novel
mobile electronic data collection tool for the building of
a web-based MDRTB contact e-registry, and we col-
lected descriptive epidemiological data on contacts.
The study was carried out in Mongolia, where in 2017
the estimated incidence rate then was 428/100,000 with
a TB disease notification rate of 136/100,000, and a case
detection rate of 32% [25]. 12.6% of laboratory con-
firmed cases were MDR [26]. MDRTB contact tracing
has been national policy since 2006, though implementa-
tion is patchy. In 2016, 5.7% of identified household con-
tacts developed active TB [26]. Contact tracing is done
through district dispensaries where patients receive dir-
ectly observed treatment (DOT).
Methods
Ethics approval and consent to participate
The study was approved by the Mongolian Ministry of
Health research ethics committee (Ref: 18) and the
London School of Hygiene and Tropical Medicine (Ref:
13882).
Consent
All participants (staff and patients) were provided writ-
ten information about the research and gave written in-
formed consent to participate, as well as to having
anonymised data shared. For children below 18 years of
age, consent was taken from a parent in addition to con-
sent from the child participant. Patients who chose not
to participate in the e-registry were also invited to
complete an optional anonymous feedback form to ex-
plain their reasoning.
Study site selection
Seven dispensaries were selected to participate based on
their case load and physical proximity. At the time of
the study 283 patients were receiving treatment for
MDR-TB across these sites, these accounted for 57% of
the national MDR-TB cases [26]. They covered six dis-
tricts, all within Ulaanbaatar city limits, facilitating ac-
cess for the investigators to as many sites as possible
within the limited time frame of the study.
Participant selection and recruitment
All staff whose role already involved contact tracing at
the selected dispensaries were invited to participate in
the study. Index patients were invited to participate
through convenience sampling if they attended any of
the study sites over the 3 week study period in August–
September 2017, and met the following inclusion cri-
teria; microbiologically confirmed MDR-TB (pulmonary
and/or extrapulmonary) and capacity to consent. Pa-
tients newly diagnosed during the study period, as well
as those already undergoing treatment were eligible.
These index patients were then asked to invite their
household and close contacts as defined below to attend
the dispensary for recruitment, who were eligible if they
too had capacity to consent. Patients were excluded
from recruitment if they lacked capacity to consent, and
index patients were excluded if they had a drug
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susceptibility pattern not consistent with MDR-TB as
defined by the WHO.
Data collection
Open Data Kit (ODK) was chosen as a convenient plat-
form for the e-registry as it is an open access software
tool used widely by LSHTM in research and outbreak
response, making it an attractive option for a project
with limited funds and meant it could be set up rapidly.
Data is entered into the ODK collect application on an-
droid tablets. The data is hosted on ODK Aggregate V ≥
1.4.15 (opendatakit.org) running on a mirrored 256-bit
encrypted Apache Tomcat server with a MySQL back-
end provided in a dual virtual server configuration pro-
tected by an enterprise firewall and hardware load balan-
cer. Both servers are replicated every 2 hours, further
backed up daily and back up data is streamed to tape
weekly. Both servers are also automatically patched with
the latest security updates.
Personal identifiable information was first collected on
a registration form which was encrypted before trans-
mission to the server, remaining encrypted until down-
loaded and decrypted with a 2048-bit RSA key. Once
data collection forms were marked as complete, they
were no longer accessible through the ODK collect ap-
plication, but the data could be accessed by the National
Centre of Communicable Diseases (NCCD) on the ODK
aggregate server, decrypted locally and emailed back to
clinics on a scheduled basis in PDF or XLS format with
end to end encryption. Patient data was not then avail-
able to view on the tablet.
For this study each dispensary was issued with an an-
droid tablet preloaded with the data collection forms on
ODK collect. Local procurement of tablets or the use of
staffs personal devices would also be feasible as the
ODK data collections forms are downloaded to each de-
vice from the aggregate server. All dispensaries were
already equipped with wired internet access, but WiFi
routers were installed to allow the tablets internet access
on-site. Security locks and applock software were in-
stalled on the tablets to prevent unauthorised access as
well as restricting the use of the tablets. All dispensary
staff had prior computer literacy with experience in
using a PC for electronic data capture, as well as per-
sonal access to smartphones. However, none had re-
ported experience of electronic data capture with a
tablet computer. All staff were trained to recruit and
consent participants, operate the tablets and app, and
provided with a written manual and contact details for
technical support. Staff continued recording all contact
tracing activities on the paper-based registries during the
study. Data was extracted into Microsoft Excel 2016 to
calculate interquartile range (IQR).
Acceptability
All staff who participated in the study underwent a
semi-structured interview after using ODK for at least 2
weeks. Patient participants and non-participants were
asked to fill out an anonymous written feedback ques-
tionnaire to determine acceptability. Responses to closed
questions were reported descriptively. Responses to open
questions were coded and themes were identified using
framework analysis [27].
Definitions
The definitions for the index case and household contact
used 2012 WHO recommendations [5], the definition
for close contact was based on the Mongolian tubercu-
losis program guidelines, which uses a higher threshold
than the WHO [28].
Index case: The initially identified patient with new or
recurrent TB in a specific household or comparable set-
ting in which others may have been exposed. Note: The
index case is the initial patient accessing healthcare, they
may not be the source case.
Household contact: A person who shared the same
enclosed living space for ≥1 nights or for frequent or ex-
tended periods during the day with the index case dur-
ing the 3months before commencement of the current
treatment episode.
Close contact: A person who is not in the household
but shares an enclosed space with the index case, such
as a place of social gathering, workplace, or facility, for
greater than 40 h per week during the 3 months before
commencement of the current treatment episode.
Results
MDRTB contact tracing in Ulaanbaatar
32 of 42 invited index patients with laboratory con-
firmed MDRTB agreed to participate in electronic regis-
tration of themselves and their contacts. The median age
of index cases was 32.5 years, 21 were female. 27 had
pulmonary disease, 4 had extra-pulmonary disease, and
1 had both. All 24 who were tested for HIV were sero-
negative. The median time from diagnosis to recruit-
ment in this study was 15months (IQR 6-20 months).
The index cases reported a total of 72 household con-
tacts (HHC) and a further 123 close contacts. HHC were
only recruited from consented index patients. Each
index case had a median of 3 HHC (IQR 1–3, Range 0–
6) and 1 close contact (IQR 0–5.5, Range 0–30). 70 of
these contacts (69 household, 1 close) attended a dis-
pensary and agreed to participate in the study.
Demographic data and investigation results were avail-
able on 68/70 contacts. The median age was 19.5 (IQR
6.75–35, range 1–57) and 35 (51%) were female. 12/68
(18%) contacts were aged under five, 5 had a low BMI,
and 1 had a fibrotic lung lesion. 25 were HIV tested and
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all of these were negative. Nine contacts had symptoms
suggestive of TB, 7 reported a cough lasting over 2
weeks, 6 reported fever, 5 reported weight loss and chest
pain, 4 reported fatigue and sweats, and 1 reported
shortness of breath. 59/68 (87%) had a chest x-ray, 10 of
which were abnormal. 7/70 (10%) of contacts screened
had laboratory confirmed secondary cases of active TB
among six households (Table 1). Six had MDRTB and
one had drug susceptible (DS) TB. Complete drug sus-
ceptibility testing (DST) was available in four secondary
MDRTB cases, three of which had an identical profile to
their index. 28 contacts underwent LTBI testing, 13/26
were TST positive, 4 had IGRA testing, all of whom
were negative, 7 received TB preventive therapy.
Staff satisfaction with e-registry system
8 of 12 trained staff involved in contact tracing during
the study were interviewed (4 doctors, 3 nurses and 1
dietician). 4/8 reported being satisfied, and 3/8 reported
being very dissatisfied with the paper-based registry.
Staff reported it ‘takes a long time to find records, espe-
cially test results’ in the paper records system and that
results paperwork and copies of x-rays were often kept
by patients making it difficult to collate the data for
quarterly reports, often duplicating work. All the staff re-
ported being satisfied with the e-registry system, and the
training received to use it. 4/8 staff stated a strong pref-
erence to use ODK for contact tracing, 3/8 slightly pre-
ferred ODK and one had no preference. All staff said
they would be happy to continue using an e-registry and
would recommend its expansion (Table 2).
Patient satisfaction with e-registry system
Thirty-nine anonymous feedback forms were completed
by index cases approached to be in the e-registry, 8/39
survey respondents did not consent to inclusion of their
details in the e-registry. Of the 31 who agreed to have
their details collected electronically 11 felt it worked very
well, 19 slightly well, and 1 slightly poorly. 28/31 (90%)
felt that the e-registry was better than paper, 2 didn’t
know and one respondent left that question blank.
The most commonly cited concern, mentioned by 12
of the survey respondents, was the security of their
data. 8 of these 12 were e-registry participants. This was
closely followed by concerns that their data may be inad-
vertently ‘lost’, and two e-registry participants were un-
happy about sharing information on their household
income stating, ‘there is no need to ask about income’.
Discussion
In this study we have developed and evaluated the feasi-
bility and acceptability of an electronic MDRTB contact
registry. A high yield of 10% (7/70) secondary TB cases
in contacts reaffirms the importance of contact tracing
and of a standardised and systematic approach to con-
tact tracing in this setting.
Most of the data collected for the MDRTB contact
registry overlaps with data collection necessary for the
MDRTB index registry; a more unified system would
therefore reduce duplication. Furthermore, many
MDRTB patients have previously been treated for drug
susceptible TB and using a common registration system
across all types of TB disease could help prevent infor-
mation on discrete sub-populations from forming data
silos. Linking records across these different registries to
avoid the duplication would be simpler in an electronic
system and offer another advantage over paper.
There is a desire to improve the current MDRTB con-
tact tracing and an e-registry is recognised as a way to
achieve this by most patients and staff. However, refusal
to participate in the e-registry by 10/42 (24%) of the
index MDRTB cases invited does raise a concern
Table 1 Characteristics of secondary TB cases
# Age, gender and exposure Intensity Symptoms Chest X-ray TST Diagnosis
1 23 F, shares a bed Cough, fever, chest pain, dyspnoea, fatigue Abnormal N/A Sm +MDR (Gene Xpert)
No DST
4 5 M, household Cough Abnormal Positive MDR
Discordant DST
11 6 F, shares a bed Nil Abnormal Positive MDR
Identical DST
15 21 M, shares bedroom Nil Abnormal N/A Sm +MDR
Identical DST
16 14 M, shares bedroom Weight loss Abnormal Positive Sm- MDR (Gene Xpert)
No DST
37 3 F, shares a bed Cough, fever, weight loss, sweats, chest pain, fatigue Abnormal N/A Sm +MDR
Identical DST
67 46 M, household Cough, fever, chest pain Normal N/A Sm- DS-TB
#: Number, DSTB Drug susceptible tuberculosis, DST Drug susceptibility testing, F Female, M Male, MDR Multidrug resistant, N/A Not applicable, Sm+: Sputum
smear positive, Sm-: Sputum smear negative
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regarding the acceptability of an e-registry hindering the
contact tracing practices. Although not identified in the
questionnaires, it is possible non-participation of indexes
may have been influenced by the nature of presenting
the e-registry as a research project co-ordinated by an
external organisation, as opposed to paper registry which
had been presented as being a routine part of their clin-
ical management. As a result, this may have heightened
the concerns regarding data security.
It is not possible for staff to view or search the registry
from the ODK collect app, meaning they needed a sep-
arate way to access patient registry numbers, essential in
linking the correct patient record. In effect, a second
paper registry was made for the ODK registry to work.
This duplication is inefficient and a potential source for
error.
There is a clear need for an e-registry that provides a
secure user interface. Two promising alternative systems
are TUBIS and DHIS2, both are web based and allow
the registry to be searched, simplifying it for users to re-
trieve patient records and add further data to the correct
record. Each of the electronic registry systems men-
tioned above have their own relative merits and limita-
tions [19]. WHO are now collaborating to provide
support for TB patient data reporting using the DHIS2
platform. Inclusion of TB contacts in this software
would be a logical next step [29, 30].
An internationally agreed minimum data set for con-
tact tracing, and adherence to the shared definitions en-
dorsed by the WHO would likely be more beneficial
than standardised data collection tools to allow these to
be more adaptable to local contexts.
Study limitations
This study has several limitations. Firstly, staff being
aware that they were taking part in a research study may
have influenced the accuracy and completeness of data
entry. Staff were not offered any incentives related to
their performance, data accuracy or interview feedback.
Conversely as the e-registry data was collected in dupli-
cate with paper data, staff might have considered data
accuracy for the e-registry to be less important.
Secondly, presenting the e-registry to patients as a
novel tool under investigation as part of a research pro-
ject, and requiring explicit informed written consent for
their participation may have in and of itself heightened
their anxiety regarding data security. The paper based
registry in contrast was presented as the default option,
with consent for data collection implied but not expli-
citly sought.
Thirdly, dispensary staff were aware that the inter-
viewers had been involved in the development of the e-
registry. This may have introduced response bias, skewing
their interview answers to be more positive to be polite
and avoid causing offence. They were asked to record an
honest and open account of the experiences using the e-
registry despite this.
Finally, all the dispensaries covered were urban or
semi-urban, the results will not necessarily reflect expe-
riences in rural areas.
Conclusions
Deployment of an e-registry for MDRTB contact tracing
is certainly technically feasible, and acceptable to the
majority of patients and staff involved. Staff perceived
benefits in reducing the likelihood of records being lost,
being able to gather data more quickly and reducing the
time taken to compile it for quarterly reports. However
reluctance to participate in the e-registry amongst a sig-
nificant minority of index patients could pose a major
challenge in shifting to such systems in future, highlight-
ing the importance of gathering patient feedback on the
roll-out of such new systems.
A user-friendly secure e-registry within which TB staff
can review patient management and provide reports,
would enable care, follow-up and adherence to WHO
Table 2 Themes identified from staff interviews and anonymous feedback forms
Advantages of ODK
• Records were less likely to be lost, particularly investigation results
• Digital photos of x-rays could be stored for comparison over time
• Easier to transfer contact tracing information for patients moving
districts
• Faster than paper, especially when using predictive text
Disadvantages of ODK
• Submitted data was not immediately visible on the device
• Registry numbers had to be entered multiple times (once on each form)
Improvements suggested by staff
• Make data more rapidly available for viewing
• Reduce the number of forms
• Allow data entry on PC
• Auto-populate certain fields e.g. follow up date
• Create a system that would automatically send out reminders
to patients via SMS/email of upcoming appointments
Reasons given to staff by patients for refusing to join registry
• Already taking part in multiple other research studies
• Didn’t have time to bring their contacts to dispensary during study period
• Concern regarding security of their data being sent electronically –
particularly that medical history would be shared on social media
Improvements suggested by patient
• To be able see their own e-record.
Reasons given on anonymous feedback forms
• Not wanting to share medical or personal data, even for research purposes
• Concern that their ‘information would be lost in the internet’
• Not understanding the purpose of the study (non-participant)
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guidance. E-registry systems should be explored for the
use of MDRTB contact tracing and should seek to meet
the following criteria:
 Accurate and secure – adequately backed up to
prevent data loss and protected against unauthorised
access
 User friendly – easy to learn, quick to use and
unambiguous questions and responses presented in
a logical manner
 Integrated into the TB and MDRTB case and
contact registry systems
 Fully self-contained - not requiring any additional
paper records to maintain the registry
 Capable of data entry offline
 Free and open source
 Accuracy of registry data should be audited
periodically to ensure standards are being
maintained
 A minimum dataset for MDRTB contact tracing
needs to be internationally agreed
 Shared definitions for surveillance and research
purposes need to be more widely embraced
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